收藏切换
Exploring medication patterns and molecular regulatory mechanisms of traditional Chinese medicine compound prescriptions in treatment of acute exacerbations of chronic obstructive pulmonary disease from perspective of basic syndrome
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(17) : 6278 - 6300
Less
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(17): 6278-6300
Exploring medication patterns and molecular regulatory mechanisms of traditional Chinese medicine compound prescriptions in treatment of acute exacerbations of chronic obstructive pulmonary disease from perspective of basic syndrome
Full
ZHANG Zhen1,2, YI Mingyang1,2, LI Weike1,2, WANG Zhiwan1,2
Affiliations
    1 National Regional Traditional Chines Medicine (Lung Disease) Diagnostic and Treatment Center, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China; 2 Provincial and Ministerial Co-constructed Collaborative Innovation Center for Prevention and Treatment of Respiratory Diseases with Traditional Chinese Medicine, Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou 450046, China
About Author:
国家科技重大专项“四大慢病重大专项” (2023ZD0506700,2023ZD0506701); 国家科学技术部重点研发计划项目 (2017YFC1700103); 国家自然科学基金面上项目 (81973791); 河南省中医药科学研究专项课题 (2024ZY1009)
doi: 10.7501/j.issn.0253-2670.2025.17.018
Outline
收藏切换
Objective To integrate data mining, bioinformatics, network pharmacology, and molecular dynamics approaches to explore the medication patterns and molecular regulatory mechanisms underlying different basic syndromes in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods Clinical research literatures on traditional Chinese medicine (TCM) compound prescriptions for treating AECOPD with syndrome type information were retrieved and collected. Information including syndrome types, prescription names, compositions, and dosages was extracted. Based on the RStudio platform, statistical description, Apriori algorithm, and Phi correlation coefficient analysis were combined to identify high-frequency basic syndromes and core TCM herbs. The ccTCM database was used to collect TCM components and their targets, with SwissADME for drug-likeness evaluation and SwissTargetPrediction for target prediction. Meanwhile, AECOPD-related disease targets were obtained from GEO, GeneCards, NCBI-Gene, and DisGeNET databases. The intersection of TCM-derived targets and disease targets was used to screen potential therapeutic targets, followed by Gene Ontology and pathway enrichment analysis via the Metascape platform. A protein-protein interaction (PPI) network was constructed based on STRING, and key therapeutic targets were screened using Cytoscape 3.9.1. Molecular docking and molecular dynamics simulation were performed for validation. Results A total of 1 306 articles were included, involving 136 syndrome types, 577 prescriptions, and 286 TCM herbs. Thirty-one basic syndromes of AECOPD were identified, with the high-frequency ones being phlegm-heat syndrome, phlegm-dampness syndrome, and blood stasis syndrome. For phlegm-heat syndrome: Core herbs were Huangqin (Scutellariae Radixs), Sangbaipi (Mori Cortex), Zhebeimu (Fritillariae Thunbergii Bulbus), Gualou (Trichosanthis Fructus), and Kuxingren (Armeniacae Semen Amarum), mapping to 159 potential therapeutic targets. Functional enrichment focused on cell motility regulation and inflammatory signal transduction, with cellular components localized in endocytic vesicles and receptor complexes. Tumor necrosis factor-α (TNF-α), signal transducer and activator of transcription 3 (STAT3), and interleukin 6 (IL6) were key therapeutic targets, optimally binding wogonoside, baicalin, and chlorogenic acid respectively, with TNF-α and wogonoside showing the highest binding score. For phlegm-dampness syndrome, core herbs were Banxia (Pinelliae Rhizoma), Chenpi (Citri Reticulatae Pericarpium), Fuling (Poria), Zisuzi (Perillae Fructus), Laifuzi (Raphani Semen), and Baijiezi (Sinapis Semen), mapping to 170 potential therapeutic targets. Functional enrichment centered on cell motility regulation and metabolic stress response, with cellular components localized in cell-matrix adhesion structures. Epidermal growth factor receptor (EGFR), TNF-α, STAT3, IL6, and protein kinase B1 (AKT1) were key therapeutic targets, optimally binding luteoloside, caffeic acid, apigenin, poricoic acid A, and 16α-hydroxytrametenolic acid respectively, with EGFR and luteoloside showing the highest binding score. For blood stasis syndrome, core herbs were Ligusticum chuanxiong Chuanxiong (Chuanxiong Rhizoma), Danshen (Salviae Miltiorrhizae Radix et Rhizoma), and Taoren (Persizae Semen), mapping to 120 potential therapeutic targets. Functional enrichment concentrated on angiogenesis, hypoxia response, and cell apoptosis, with cellular components localized in cell-matrix adhesion structures. Matrix metalloproteinase-9 (MMP-9), B-cell lymphoma-2 (BCL2), interleukin-1β (IL1B), Toll-like receptor 4 (TLR4), TNF-α, STAT3, and AKT1 were key therapeutic targets, optimally binding salvianolic acid B, dihydrotanshinone I, rosmarinic acid, ferulic acid, caffeic acid, 4-terpineol, and senkyunolide A respectively, with MMP-9 and salvianolic acid B showing the highest binding score. Molecular dynamics simulation verified that the wogonoside-TNF-α, luteoloside-EGFR, and salvianolic acid B-MMP-9 complexes demonstrated good stability. Conclusion This study elucidates the scientific connotation of “treating the same disease with different methods” at the molecular level. Phlegm-heat, phlegm-dampness, and blood stasis are important pathological mechanisms in the pathogenesis of AECOPD. The regulatory mechanisms of core TCM herbs for different basic syndromes exhibit significant differences. The combinations of wogonoside-TNF-α, luteoloside-EGFR, and salvianolic acid B-MMP-9 are noteworthy mechanistic pairs in AECOPD research.
acute exacerbation of chronic obstructive pulmonary disease  /  basic syndrome  /  data mining  /  network pharmacology  /  bioinformatics  /  molecular dynamics simulation  /  treating same disease with different methods  /  phlegm-heat syndrome  /  phlegm-dampness syndrome  /  blood stasis syndrome  /  wogonoside  /  luteoloside  /  salvianolic acid B  /  TNF-α  /  EGFR  /  MMP-9
张真, 伊明洋, 李伟珂, 王至婉. 从基础证探讨中药复方治疗慢性阻塞性肺疾病急性加重的用药规律及分子调控机制. 中草药, 2025 , 56 (17) : 6278 -6300 . DOI: 10.7501/j.issn.0253-2670.2025.17.018
ZHANG Zhen, YI Mingyang, LI Weike, WANG Zhiwan. Exploring medication patterns and molecular regulatory mechanisms of traditional Chinese medicine compound prescriptions in treatment of acute exacerbations of chronic obstructive pulmonary disease from perspective of basic syndrome[J]. Chinese Traditional and Herbal Drugs, 2025 , 56 (17) : 6278 -6300 . DOI: 10.7501/j.issn.0253-2670.2025.17.018
Year 2025 volume 56 Issue 17
48
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.17.018
  • Receive Date:2025-06-19
  • Online Date:2026-11-12
Article Data
Affiliations
History
  • Received:2025-06-19
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2025.17.018
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT